EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?

Broncho-pulmonary neuroendocrine neoplasms (BP-NENs) are neoplasms orphan of an efficient therapy. Available medical treatments derived from clinical trials are not specific for the management of this malignancy. Sunitinib is a multi-receptor tyrosine-kinases (RTKs) inhibitor that has already shown...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocr Connect
Autors principals: Bresciani, Giulia, Ditsiou, Angeliki, Cilibrasi, Chiara, Vella, Viviana, Rea, Federico, Schiavon, Marco, Cavallesco, Narciso Giorgio, Giamas, Georgios, Zatelli, Maria Chiara, Gagliano, Teresa
Format: Artigo
Idioma:Inglês
Publicat: Bioscientifica Ltd 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528406/
https://ncbi.nlm.nih.gov/pubmed/31035254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0192
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars